Analyst
Individual Investor
Equibles does not estimate personal net worth.
Sharath is recorded as Analyst at Individual Investor. Sharath has spoken on 1 earnings call across 1 company, most recently for Beta Drugs Limited on May 15, 2026. The companies whose calls Sharath spoke on are classified in the Healthcare sector.
“We had mentioned in the note with the result that because the interest component on CCT, our net profit would have been higher by about 6.5 crores. But ideally, our monthly expense is interest expenditures from 4 crores.”
Individual Investor
Analyst
Transcript header (unverified)
Beta Drugs Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Beta Drugs Limited
